OCTA and Polypoidal Choroidal Vasculopathy
NCT04714242
·
clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Polypoidal Choroidal Vasculopathy
Interventions
DRUG:
Ranibizumab Injection
Sponsor
Federico II University